Development of automated high-throughput workflows for drug discovery using iPSC-derived cell types

You will learn:

• High-throughput automated workflows for ioCells enable seamless seeding, culture, and analysis in 384-well plates, ensuring the physiological relevance of iPSC-derived models at scale

• Critical optimisation parameters, including seeding density, liquid handling speeds, and media change schedules, are essential for maintaining cell viability and phenotypic consistency when transitioning from manual to automated protocols

• Validated end-point assays, such as Cell Painting and dPCR/ICC analysis, demonstrate that opti-ox technology enables the lot-to-lot consistency required for rigorous drug discovery pipelines